Biodesix (BDSX) FCF Margin (2019 - 2026)

Biodesix (BDSX) has 8 years of FCF Margin data on file, last reported at 40.11% in Q1 2026.

• Quarterly FCF Margin rose 771.0% year-over-year to 40.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26.22% (up 3411.0% YoY) and the FY2025 annual result came in at 26.59%, up 4615.0% from the prior year.
• FCF Margin declined to 40.11% in Q1 2026, from 2.41% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 52.39% in Q4 2023 to a low of 192.93% in Q1 2022.
• A 5-year average of 72.66% and a median of 60.06% in 2024 frame the typical range for FCF Margin.
• Annual changes were most pronounced in 2022 — FCF Margin slumped 15447 bps — and 2023, when it jumped 19899 bps.
• Tracing BDSX's FCF Margin over 5 years: stood at 146.6% in 2022, then soared by 136 bps to 52.39% in 2023, then tumbled by 146 bps to 24.16% in 2024, then jumped by 110 bps to 2.41% in 2025, then plunged by 1767 bps to 40.11% in 2026.
• The last three FCF Margin figures came in at 40.11% (Q1 2026), 2.41% (Q4 2025), and 41.01% (Q3 2025), per Business Quant data.